In vitro, our research group identified a reduced number of MAMs correlating with reduced PC levels using iPSCs-derived spinal MNs and oligodendrocyte progenitor cells (OPCs) from ALS patients harboring FUS mutations (P525L and R521H) [196, 197]. Here, FUS is linked to amyotrophic lateral sclerosis.